Point-of-Care Molecular Diagnostics Market Set to Reach $11.1 Billion by 2033, at a 9.7% of CAGR
The point-of-care molecular diagnostics market is poised for substantial growth, with an estimated valuation of USD 4.4 billion in 2023 and projections indicating a rise to USD 11.1 billion by 2033. [read full press release…]